Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH - 3 days ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 9 months ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - about 1 year ago
2	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Cardio Drugs and Dementia; Fampridine and Working Memory; Alzheimer's and Cancer - 5 days ago Weekend Warriors and Dementia; Iron Chelation and Alzheimer's; Neuro Drug Costs Rise - 19 days ago Omega-3 Supplements Show Benefit in APOE4 Carriers - 23 days ago Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizures - 4 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 8 months ago Alzheimer's Supplements Fail Compared With Generic Drugs - 9 months ago Dietary Thiamine Linked With Cognition - 9 months ago Twins and Dementia; CRISPR and Alzheimer's; BTK Inhibitor Fails in MS Trials - 12 months ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Results of ELEVATUM Show Improvement in Diabetic Macular Edema With Vabysmo for Racial, Ethnic Minority Patients - 20 days ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 5 months ago FDA Approves Expanded Indication for Tenofovir Alafenamide as Hepatitis B Treatment - 8 months ago FDA Approves Vadadustat for Oral Treatment of Anemia Due to Chronic Kidney Disease - 8 months ago FDA Grants Orphan Drug Designation to Felzartamab for Kidney Transplant Recipients - 8 months ago FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 8 months ago FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B - 10 months ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - 11 months ago FDA Approves IVIG for Pediatric Patients Aged 2 and Older With Primary Humoral Immunodeficiency - 12 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago
4	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	Metformin and Congenital Abnormalities; Deprescribing in Patients With Dementia - 29 days ago
5	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Pharmacists Can Suggest Increased Vitamin B12 Consumption to Prevent and Treat Acute Pancreatitis - about 1 month ago Pharmacists Can Recommend Vitamin B1 to Cure Chronic Fatigue Linked With Bowel Conditions - 2 months ago Study: Lack of Nutritional Value Found in Almost 60% of US Baby Food - 3 months ago Orange Juice Can Aid Absorption of Iron - 4 months ago Study: Vitamin D Could Alleviate Negative Impacts of Monosodium Glutamate - 5 months ago Study: Blended Antioxidant Supplement Could Improve Age-Related Health Decline - 8 months ago FDA Approves Updated Label for Bempedoic Acid, Ezetimibe Tablets - 12 months ago
6	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	BMS’ next act for Cobenfy — and other highs and lows in Alzheimer’s - about 1 month ago
7	The Conversation Science Alert Science news. Official account. Australia science news	Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients - 3 months ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Pharmalittle: We’re reading about a negative U.K. review of Leqembi, Bavarian Nordic’s strong earnings, and more - 3 months ago STAT+: Biogen’s tau-lowering drug slows cognitive decline in early study of Alzheimer’s disease - about 1 year ago
9	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: U.K.’s cost-effectiveness agency gives negative review of Alzheimer’s drug Leqembi - 3 months ago
10	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 5 months ago Faricimab Outcomes in the Real World - 12 months ago

Journalists covering benfotiamine